English
简体中文
Total: £ 56.28
Published Date: 2025-07-15 | Pages: 102 | Tables: 110 | Medical Care
The global market for First-in-Human Clinical Trial was valued at US$ 65.3 million in the year 2024 and is projected to reach a revised size of US$ 157 million by 2031, growing at a CAGR of 13.5% during the forecast period.
First-in-Human Clinical Trial is the initial stage of testing a new drug, biologic, or medical device in human subjects after successful laboratory and preclinical studies. This trial is designed to evaluate the safety, tolerability, pharmacokinetics, and sometimes early signs of effectiveness of the investigational product. It typically involves a small number of healthy volunteers or, in some cases, patients, and is conducted under strict regulatory and ethical oversight. The primary goal is to determine how the human body responds to the treatment and to identify any potential risks before proceeding to larger clinical studies.
North American market for First-in-Human Clinical Trial is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for First-in-Human Clinical Trial is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for First-in-Human Clinical Trial in Pharmaceutical is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of First-in-Human Clinical Trial include Precision for Medicine, Altasciences, hVIVO, QPS Holdings, Worldwide Clinical Trials, Veeda Lifesciences, CMAX, Hammersmith Medicines Research, Allucent, Aixial Group, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for First-in-Human Clinical Trial, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding First-in-Human Clinical Trial.
The First-in-Human Clinical Trial market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global First-in-Human Clinical Trial market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the First-in-Human Clinical Trial companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Precision for Medicine
Altasciences
hVIVO
QPS Holdings
Worldwide Clinical Trials
Veeda Lifesciences
CMAX
Hammersmith Medicines Research
Allucent
Aixial Group
Icon Group
BioPharma Services
Simbec-Orion
The Micron Group
BDD
TRACER
Sofpromed
Datapharm Australia
3S Pharma
bioaccess
Pharmaron
WuXi Clinical (WuXi AppTec)
Segment by Type
Single Ascending Dose
Multiple Ascending Dose
Others
Segment by Application
Pharmaceutical
Vaccine
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of First-in-Human Clinical Trial company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global First-in-Human Clinical Trial Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Single Ascending Dose
1.2.3 Multiple Ascending Dose
1.2.4 Others
1.3 Market by Application
1.3.1 Global First-in-Human Clinical Trial Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical
1.3.3 Vaccine
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global First-in-Human Clinical Trial Market Perspective (2020-2031)
2.2 Global First-in-Human Clinical Trial Growth Trends by Region
2.2.1 Global First-in-Human Clinical Trial Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 First-in-Human Clinical Trial Historic Market Size by Region (2020-2025)
2.2.3 First-in-Human Clinical Trial Forecasted Market Size by Region (2026-2031)
2.3 First-in-Human Clinical Trial Market Dynamics
2.3.1 First-in-Human Clinical Trial Industry Trends
2.3.2 First-in-Human Clinical Trial Market Drivers
2.3.3 First-in-Human Clinical Trial Market Challenges
2.3.4 First-in-Human Clinical Trial Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top First-in-Human Clinical Trial Players by Revenue
3.1.1 Global Top First-in-Human Clinical Trial Players by Revenue (2020-2025)
3.1.2 Global First-in-Human Clinical Trial Revenue Market Share by Players (2020-2025)
3.2 Global Top First-in-Human Clinical Trial Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by First-in-Human Clinical Trial Revenue
3.4 Global First-in-Human Clinical Trial Market Concentration Ratio
3.4.1 Global First-in-Human Clinical Trial Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by First-in-Human Clinical Trial Revenue in 2024
3.5 Global Key Players of First-in-Human Clinical Trial Head office and Area Served
3.6 Global Key Players of First-in-Human Clinical Trial, Product and Application
3.7 Global Key Players of First-in-Human Clinical Trial, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 First-in-Human Clinical Trial Breakdown Data by Type
4.1 Global First-in-Human Clinical Trial Historic Market Size by Type (2020-2025)
4.2 Global First-in-Human Clinical Trial Forecasted Market Size by Type (2026-2031)
5 First-in-Human Clinical Trial Breakdown Data by Application
5.1 Global First-in-Human Clinical Trial Historic Market Size by Application (2020-2025)
5.2 Global First-in-Human Clinical Trial Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America First-in-Human Clinical Trial Market Size (2020-2031)
6.2 North America First-in-Human Clinical Trial Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America First-in-Human Clinical Trial Market Size by Country (2020-2025)
6.4 North America First-in-Human Clinical Trial Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe First-in-Human Clinical Trial Market Size (2020-2031)
7.2 Europe First-in-Human Clinical Trial Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe First-in-Human Clinical Trial Market Size by Country (2020-2025)
7.4 Europe First-in-Human Clinical Trial Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific First-in-Human Clinical Trial Market Size (2020-2031)
8.2 Asia-Pacific First-in-Human Clinical Trial Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific First-in-Human Clinical Trial Market Size by Region (2020-2025)
8.4 Asia-Pacific First-in-Human Clinical Trial Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America First-in-Human Clinical Trial Market Size (2020-2031)
9.2 Latin America First-in-Human Clinical Trial Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America First-in-Human Clinical Trial Market Size by Country (2020-2025)
9.4 Latin America First-in-Human Clinical Trial Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa First-in-Human Clinical Trial Market Size (2020-2031)
10.2 Middle East & Africa First-in-Human Clinical Trial Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa First-in-Human Clinical Trial Market Size by Country (2020-2025)
10.4 Middle East & Africa First-in-Human Clinical Trial Market Size by Country (2026-2031)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Precision for Medicine
11.1.1 Precision for Medicine Company Details
11.1.2 Precision for Medicine Business Overview
11.1.3 Precision for Medicine First-in-Human Clinical Trial Introduction
11.1.4 Precision for Medicine Revenue in First-in-Human Clinical Trial Business (2020-2025)
11.1.5 Precision for Medicine Recent Development
11.2 Altasciences
11.2.1 Altasciences Company Details
11.2.2 Altasciences Business Overview
11.2.3 Altasciences First-in-Human Clinical Trial Introduction
11.2.4 Altasciences Revenue in First-in-Human Clinical Trial Business (2020-2025)
11.2.5 Altasciences Recent Development
11.3 hVIVO
11.3.1 hVIVO Company Details
11.3.2 hVIVO Business Overview
11.3.3 hVIVO First-in-Human Clinical Trial Introduction
11.3.4 hVIVO Revenue in First-in-Human Clinical Trial Business (2020-2025)
11.3.5 hVIVO Recent Development
11.4 QPS Holdings
11.4.1 QPS Holdings Company Details
11.4.2 QPS Holdings Business Overview
11.4.3 QPS Holdings First-in-Human Clinical Trial Introduction
11.4.4 QPS Holdings Revenue in First-in-Human Clinical Trial Business (2020-2025)
11.4.5 QPS Holdings Recent Development
11.5 Worldwide Clinical Trials
11.5.1 Worldwide Clinical Trials Company Details
11.5.2 Worldwide Clinical Trials Business Overview
11.5.3 Worldwide Clinical Trials First-in-Human Clinical Trial Introduction
11.5.4 Worldwide Clinical Trials Revenue in First-in-Human Clinical Trial Business (2020-2025)
11.5.5 Worldwide Clinical Trials Recent Development
11.6 Veeda Lifesciences
11.6.1 Veeda Lifesciences Company Details
11.6.2 Veeda Lifesciences Business Overview
11.6.3 Veeda Lifesciences First-in-Human Clinical Trial Introduction
11.6.4 Veeda Lifesciences Revenue in First-in-Human Clinical Trial Business (2020-2025)
11.6.5 Veeda Lifesciences Recent Development
11.7 CMAX
11.7.1 CMAX Company Details
11.7.2 CMAX Business Overview
11.7.3 CMAX First-in-Human Clinical Trial Introduction
11.7.4 CMAX Revenue in First-in-Human Clinical Trial Business (2020-2025)
11.7.5 CMAX Recent Development
11.8 Hammersmith Medicines Research
11.8.1 Hammersmith Medicines Research Company Details
11.8.2 Hammersmith Medicines Research Business Overview
11.8.3 Hammersmith Medicines Research First-in-Human Clinical Trial Introduction
11.8.4 Hammersmith Medicines Research Revenue in First-in-Human Clinical Trial Business (2020-2025)
11.8.5 Hammersmith Medicines Research Recent Development
11.9 Allucent
11.9.1 Allucent Company Details
11.9.2 Allucent Business Overview
11.9.3 Allucent First-in-Human Clinical Trial Introduction
11.9.4 Allucent Revenue in First-in-Human Clinical Trial Business (2020-2025)
11.9.5 Allucent Recent Development
11.10 Aixial Group
11.10.1 Aixial Group Company Details
11.10.2 Aixial Group Business Overview
11.10.3 Aixial Group First-in-Human Clinical Trial Introduction
11.10.4 Aixial Group Revenue in First-in-Human Clinical Trial Business (2020-2025)
11.10.5 Aixial Group Recent Development
11.11 Icon Group
11.11.1 Icon Group Company Details
11.11.2 Icon Group Business Overview
11.11.3 Icon Group First-in-Human Clinical Trial Introduction
11.11.4 Icon Group Revenue in First-in-Human Clinical Trial Business (2020-2025)
11.11.5 Icon Group Recent Development
11.12 BioPharma Services
11.12.1 BioPharma Services Company Details
11.12.2 BioPharma Services Business Overview
11.12.3 BioPharma Services First-in-Human Clinical Trial Introduction
11.12.4 BioPharma Services Revenue in First-in-Human Clinical Trial Business (2020-2025)
11.12.5 BioPharma Services Recent Development
11.13 Simbec-Orion
11.13.1 Simbec-Orion Company Details
11.13.2 Simbec-Orion Business Overview
11.13.3 Simbec-Orion First-in-Human Clinical Trial Introduction
11.13.4 Simbec-Orion Revenue in First-in-Human Clinical Trial Business (2020-2025)
11.13.5 Simbec-Orion Recent Development
11.14 The Micron Group
11.14.1 The Micron Group Company Details
11.14.2 The Micron Group Business Overview
11.14.3 The Micron Group First-in-Human Clinical Trial Introduction
11.14.4 The Micron Group Revenue in First-in-Human Clinical Trial Business (2020-2025)
11.14.5 The Micron Group Recent Development
11.15 BDD
11.15.1 BDD Company Details
11.15.2 BDD Business Overview
11.15.3 BDD First-in-Human Clinical Trial Introduction
11.15.4 BDD Revenue in First-in-Human Clinical Trial Business (2020-2025)
11.15.5 BDD Recent Development
11.16 TRACER
11.16.1 TRACER Company Details
11.16.2 TRACER Business Overview
11.16.3 TRACER First-in-Human Clinical Trial Introduction
11.16.4 TRACER Revenue in First-in-Human Clinical Trial Business (2020-2025)
11.16.5 TRACER Recent Development
11.17 Sofpromed
11.17.1 Sofpromed Company Details
11.17.2 Sofpromed Business Overview
11.17.3 Sofpromed First-in-Human Clinical Trial Introduction
11.17.4 Sofpromed Revenue in First-in-Human Clinical Trial Business (2020-2025)
11.17.5 Sofpromed Recent Development
11.18 Datapharm Australia
11.18.1 Datapharm Australia Company Details
11.18.2 Datapharm Australia Business Overview
11.18.3 Datapharm Australia First-in-Human Clinical Trial Introduction
11.18.4 Datapharm Australia Revenue in First-in-Human Clinical Trial Business (2020-2025)
11.18.5 Datapharm Australia Recent Development
11.19 3S Pharma
11.19.1 3S Pharma Company Details
11.19.2 3S Pharma Business Overview
11.19.3 3S Pharma First-in-Human Clinical Trial Introduction
11.19.4 3S Pharma Revenue in First-in-Human Clinical Trial Business (2020-2025)
11.19.5 3S Pharma Recent Development
11.20 bioaccess
11.20.1 bioaccess Company Details
11.20.2 bioaccess Business Overview
11.20.3 bioaccess First-in-Human Clinical Trial Introduction
11.20.4 bioaccess Revenue in First-in-Human Clinical Trial Business (2020-2025)
11.20.5 bioaccess Recent Development
11.21 Pharmaron
11.21.1 Pharmaron Company Details
11.21.2 Pharmaron Business Overview
11.21.3 Pharmaron First-in-Human Clinical Trial Introduction
11.21.4 Pharmaron Revenue in First-in-Human Clinical Trial Business (2020-2025)
11.21.5 Pharmaron Recent Development
11.22 WuXi Clinical (WuXi AppTec)
11.22.1 WuXi Clinical (WuXi AppTec) Company Details
11.22.2 WuXi Clinical (WuXi AppTec) Business Overview
11.22.3 WuXi Clinical (WuXi AppTec) First-in-Human Clinical Trial Introduction
11.22.4 WuXi Clinical (WuXi AppTec) Revenue in First-in-Human Clinical Trial Business (2020-2025)
11.22.5 WuXi Clinical (WuXi AppTec) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global First-in-Human Clinical Trial Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Single Ascending Dose
Table 3. Key Players of Multiple Ascending Dose
Table 4. Key Players of Others
Table 5. Global First-in-Human Clinical Trial Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global First-in-Human Clinical Trial Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global First-in-Human Clinical Trial Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global First-in-Human Clinical Trial Market Share by Region (2020-2025)
Table 9. Global First-in-Human Clinical Trial Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global First-in-Human Clinical Trial Market Share by Region (2026-2031)
Table 11. First-in-Human Clinical Trial Market Trends
Table 12. First-in-Human Clinical Trial Market Drivers
Table 13. First-in-Human Clinical Trial Market Challenges
Table 14. First-in-Human Clinical Trial Market Restraints
Table 15. Global First-in-Human Clinical Trial Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global First-in-Human Clinical Trial Market Share by Players (2020-2025)
Table 17. Global Top First-in-Human Clinical Trial Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in First-in-Human Clinical Trial as of 2024)
Table 18. Ranking of Global Top First-in-Human Clinical Trial Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by First-in-Human Clinical Trial Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of First-in-Human Clinical Trial, Headquarters and Area Served
Table 21. Global Key Players of First-in-Human Clinical Trial, Product and Application
Table 22. Global Key Players of First-in-Human Clinical Trial, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global First-in-Human Clinical Trial Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global First-in-Human Clinical Trial Revenue Market Share by Type (2020-2025)
Table 26. Global First-in-Human Clinical Trial Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global First-in-Human Clinical Trial Revenue Market Share by Type (2026-2031)
Table 28. Global First-in-Human Clinical Trial Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global First-in-Human Clinical Trial Revenue Market Share by Application (2020-2025)
Table 30. Global First-in-Human Clinical Trial Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global First-in-Human Clinical Trial Revenue Market Share by Application (2026-2031)
Table 32. North America First-in-Human Clinical Trial Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America First-in-Human Clinical Trial Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America First-in-Human Clinical Trial Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe First-in-Human Clinical Trial Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe First-in-Human Clinical Trial Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe First-in-Human Clinical Trial Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific First-in-Human Clinical Trial Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific First-in-Human Clinical Trial Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific First-in-Human Clinical Trial Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America First-in-Human Clinical Trial Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America First-in-Human Clinical Trial Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America First-in-Human Clinical Trial Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa First-in-Human Clinical Trial Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa First-in-Human Clinical Trial Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa First-in-Human Clinical Trial Market Size by Country (2026-2031) & (US$ Million)
Table 47. Precision for Medicine Company Details
Table 48. Precision for Medicine Business Overview
Table 49. Precision for Medicine First-in-Human Clinical Trial Product
Table 50. Precision for Medicine Revenue in First-in-Human Clinical Trial Business (2020-2025) & (US$ Million)
Table 51. Precision for Medicine Recent Development
Table 52. Altasciences Company Details
Table 53. Altasciences Business Overview
Table 54. Altasciences First-in-Human Clinical Trial Product
Table 55. Altasciences Revenue in First-in-Human Clinical Trial Business (2020-2025) & (US$ Million)
Table 56. Altasciences Recent Development
Table 57. hVIVO Company Details
Table 58. hVIVO Business Overview
Table 59. hVIVO First-in-Human Clinical Trial Product
Table 60. hVIVO Revenue in First-in-Human Clinical Trial Business (2020-2025) & (US$ Million)
Table 61. hVIVO Recent Development
Table 62. QPS Holdings Company Details
Table 63. QPS Holdings Business Overview
Table 64. QPS Holdings First-in-Human Clinical Trial Product
Table 65. QPS Holdings Revenue in First-in-Human Clinical Trial Business (2020-2025) & (US$ Million)
Table 66. QPS Holdings Recent Development
Table 67. Worldwide Clinical Trials Company Details
Table 68. Worldwide Clinical Trials Business Overview
Table 69. Worldwide Clinical Trials First-in-Human Clinical Trial Product
Table 70. Worldwide Clinical Trials Revenue in First-in-Human Clinical Trial Business (2020-2025) & (US$ Million)
Table 71. Worldwide Clinical Trials Recent Development
Table 72. Veeda Lifesciences Company Details
Table 73. Veeda Lifesciences Business Overview
Table 74. Veeda Lifesciences First-in-Human Clinical Trial Product
Table 75. Veeda Lifesciences Revenue in First-in-Human Clinical Trial Business (2020-2025) & (US$ Million)
Table 76. Veeda Lifesciences Recent Development
Table 77. CMAX Company Details
Table 78. CMAX Business Overview
Table 79. CMAX First-in-Human Clinical Trial Product
Table 80. CMAX Revenue in First-in-Human Clinical Trial Business (2020-2025) & (US$ Million)
Table 81. CMAX Recent Development
Table 82. Hammersmith Medicines Research Company Details
Table 83. Hammersmith Medicines Research Business Overview
Table 84. Hammersmith Medicines Research First-in-Human Clinical Trial Product
Table 85. Hammersmith Medicines Research Revenue in First-in-Human Clinical Trial Business (2020-2025) & (US$ Million)
Table 86. Hammersmith Medicines Research Recent Development
Table 87. Allucent Company Details
Table 88. Allucent Business Overview
Table 89. Allucent First-in-Human Clinical Trial Product
Table 90. Allucent Revenue in First-in-Human Clinical Trial Business (2020-2025) & (US$ Million)
Table 91. Allucent Recent Development
Table 92. Aixial Group Company Details
Table 93. Aixial Group Business Overview
Table 94. Aixial Group First-in-Human Clinical Trial Product
Table 95. Aixial Group Revenue in First-in-Human Clinical Trial Business (2020-2025) & (US$ Million)
Table 96. Aixial Group Recent Development
Table 97. Icon Group Company Details
Table 98. Icon Group Business Overview
Table 99. Icon Group First-in-Human Clinical Trial Product
Table 100. Icon Group Revenue in First-in-Human Clinical Trial Business (2020-2025) & (US$ Million)
Table 101. Icon Group Recent Development
Table 102. BioPharma Services Company Details
Table 103. BioPharma Services Business Overview
Table 104. BioPharma Services First-in-Human Clinical Trial Product
Table 105. BioPharma Services Revenue in First-in-Human Clinical Trial Business (2020-2025) & (US$ Million)
Table 106. BioPharma Services Recent Development
Table 107. Simbec-Orion Company Details
Table 108. Simbec-Orion Business Overview
Table 109. Simbec-Orion First-in-Human Clinical Trial Product
Table 110. Simbec-Orion Revenue in First-in-Human Clinical Trial Business (2020-2025) & (US$ Million)
Table 111. Simbec-Orion Recent Development
Table 112. The Micron Group Company Details
Table 113. The Micron Group Business Overview
Table 114. The Micron Group First-in-Human Clinical Trial Product
Table 115. The Micron Group Revenue in First-in-Human Clinical Trial Business (2020-2025) & (US$ Million)
Table 116. The Micron Group Recent Development
Table 117. BDD Company Details
Table 118. BDD Business Overview
Table 119. BDD First-in-Human Clinical Trial Product
Table 120. BDD Revenue in First-in-Human Clinical Trial Business (2020-2025) & (US$ Million)
Table 121. BDD Recent Development
Table 122. TRACER Company Details
Table 123. TRACER Business Overview
Table 124. TRACER First-in-Human Clinical Trial Product
Table 125. TRACER Revenue in First-in-Human Clinical Trial Business (2020-2025) & (US$ Million)
Table 126. TRACER Recent Development
Table 127. Sofpromed Company Details
Table 128. Sofpromed Business Overview
Table 129. Sofpromed First-in-Human Clinical Trial Product
Table 130. Sofpromed Revenue in First-in-Human Clinical Trial Business (2020-2025) & (US$ Million)
Table 131. Sofpromed Recent Development
Table 132. Datapharm Australia Company Details
Table 133. Datapharm Australia Business Overview
Table 134. Datapharm Australia First-in-Human Clinical Trial Product
Table 135. Datapharm Australia Revenue in First-in-Human Clinical Trial Business (2020-2025) & (US$ Million)
Table 136. Datapharm Australia Recent Development
Table 137. 3S Pharma Company Details
Table 138. 3S Pharma Business Overview
Table 139. 3S Pharma First-in-Human Clinical Trial Product
Table 140. 3S Pharma Revenue in First-in-Human Clinical Trial Business (2020-2025) & (US$ Million)
Table 141. 3S Pharma Recent Development
Table 142. bioaccess Company Details
Table 143. bioaccess Business Overview
Table 144. bioaccess First-in-Human Clinical Trial Product
Table 145. bioaccess Revenue in First-in-Human Clinical Trial Business (2020-2025) & (US$ Million)
Table 146. bioaccess Recent Development
Table 147. Pharmaron Company Details
Table 148. Pharmaron Business Overview
Table 149. Pharmaron First-in-Human Clinical Trial Product
Table 150. Pharmaron Revenue in First-in-Human Clinical Trial Business (2020-2025) & (US$ Million)
Table 151. Pharmaron Recent Development
Table 152. WuXi Clinical (WuXi AppTec) Company Details
Table 153. WuXi Clinical (WuXi AppTec) Business Overview
Table 154. WuXi Clinical (WuXi AppTec) First-in-Human Clinical Trial Product
Table 155. WuXi Clinical (WuXi AppTec) Revenue in First-in-Human Clinical Trial Business (2020-2025) & (US$ Million)
Table 156. WuXi Clinical (WuXi AppTec) Recent Development
Table 157. Research Programs/Design for This Report
Table 158. Key Data Information from Secondary Sources
Table 159. Key Data Information from Primary Sources
Table 160. Authors List of This Report
List of Figures
Figure 1. First-in-Human Clinical Trial Picture
Figure 2. Global First-in-Human Clinical Trial Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global First-in-Human Clinical Trial Market Share by Type: 2024 VS 2031
Figure 4. Single Ascending Dose Features
Figure 5. Multiple Ascending Dose Features
Figure 6. Others Features
Figure 7. Global First-in-Human Clinical Trial Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global First-in-Human Clinical Trial Market Share by Application: 2024 VS 2031
Figure 9. Pharmaceutical Case Studies
Figure 10. Vaccine Case Studies
Figure 11. Others Case Studies
Figure 12. First-in-Human Clinical Trial Report Years Considered
Figure 13. Global First-in-Human Clinical Trial Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global First-in-Human Clinical Trial Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global First-in-Human Clinical Trial Market Share by Region: 2024 VS 2031
Figure 16. Global First-in-Human Clinical Trial Market Share by Players in 2024
Figure 17. Global First-in-Human Clinical Trial Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 18. The Top 10 and 5 Players Market Share by First-in-Human Clinical Trial Revenue in 2024
Figure 19. North America First-in-Human Clinical Trial Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America First-in-Human Clinical Trial Market Share by Country (2020-2031)
Figure 21. United States First-in-Human Clinical Trial Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada First-in-Human Clinical Trial Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe First-in-Human Clinical Trial Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe First-in-Human Clinical Trial Market Share by Country (2020-2031)
Figure 25. Germany First-in-Human Clinical Trial Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France First-in-Human Clinical Trial Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. First-in-Human Clinical Trial Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy First-in-Human Clinical Trial Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia First-in-Human Clinical Trial Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Ireland First-in-Human Clinical Trial Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific First-in-Human Clinical Trial Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific First-in-Human Clinical Trial Market Share by Region (2020-2031)
Figure 33. China First-in-Human Clinical Trial Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan First-in-Human Clinical Trial Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea First-in-Human Clinical Trial Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia First-in-Human Clinical Trial Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India First-in-Human Clinical Trial Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia & New Zealand First-in-Human Clinical Trial Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America First-in-Human Clinical Trial Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America First-in-Human Clinical Trial Market Share by Country (2020-2031)
Figure 41. Mexico First-in-Human Clinical Trial Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil First-in-Human Clinical Trial Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa First-in-Human Clinical Trial Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa First-in-Human Clinical Trial Market Share by Country (2020-2031)
Figure 45. Israel First-in-Human Clinical Trial Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia First-in-Human Clinical Trial Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE First-in-Human Clinical Trial Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Precision for Medicine Revenue Growth Rate in First-in-Human Clinical Trial Business (2020-2025)
Figure 49. Altasciences Revenue Growth Rate in First-in-Human Clinical Trial Business (2020-2025)
Figure 50. hVIVO Revenue Growth Rate in First-in-Human Clinical Trial Business (2020-2025)
Figure 51. QPS Holdings Revenue Growth Rate in First-in-Human Clinical Trial Business (2020-2025)
Figure 52. Worldwide Clinical Trials Revenue Growth Rate in First-in-Human Clinical Trial Business (2020-2025)
Figure 53. Veeda Lifesciences Revenue Growth Rate in First-in-Human Clinical Trial Business (2020-2025)
Figure 54. CMAX Revenue Growth Rate in First-in-Human Clinical Trial Business (2020-2025)
Figure 55. Hammersmith Medicines Research Revenue Growth Rate in First-in-Human Clinical Trial Business (2020-2025)
Figure 56. Allucent Revenue Growth Rate in First-in-Human Clinical Trial Business (2020-2025)
Figure 57. Aixial Group Revenue Growth Rate in First-in-Human Clinical Trial Business (2020-2025)
Figure 58. Icon Group Revenue Growth Rate in First-in-Human Clinical Trial Business (2020-2025)
Figure 59. BioPharma Services Revenue Growth Rate in First-in-Human Clinical Trial Business (2020-2025)
Figure 60. Simbec-Orion Revenue Growth Rate in First-in-Human Clinical Trial Business (2020-2025)
Figure 61. The Micron Group Revenue Growth Rate in First-in-Human Clinical Trial Business (2020-2025)
Figure 62. BDD Revenue Growth Rate in First-in-Human Clinical Trial Business (2020-2025)
Figure 63. TRACER Revenue Growth Rate in First-in-Human Clinical Trial Business (2020-2025)
Figure 64. Sofpromed Revenue Growth Rate in First-in-Human Clinical Trial Business (2020-2025)
Figure 65. Datapharm Australia Revenue Growth Rate in First-in-Human Clinical Trial Business (2020-2025)
Figure 66. 3S Pharma Revenue Growth Rate in First-in-Human Clinical Trial Business (2020-2025)
Figure 67. bioaccess Revenue Growth Rate in First-in-Human Clinical Trial Business (2020-2025)
Figure 68. Pharmaron Revenue Growth Rate in First-in-Human Clinical Trial Business (2020-2025)
Figure 69. WuXi Clinical (WuXi AppTec) Revenue Growth Rate in First-in-Human Clinical Trial Business (2020-2025)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
